Dr. Lublin describes the latest data on some of the emerging MS therapies now in late-stage clinical trials (teriflunomide, ocrelizumab and ofatumumab), presented on ECTRIMS.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More